Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The author advocates for a permanent U.S. strategy of vaccine diplomacy, combining ambitious targets for rapid vaccine development and manufacturing with the diplomatic infrastructure needed for global distribution. The text suggests that maintaining 'warm' infrastructure through annual exercises and supporting organizations like Gavi can prevent future outbreaks from reaching pandemic scale and protect U.S. interests by limiting the emergence of dangerous mutations.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • The United States has donated and shipped over 100 million COVID-19 vaccine doses to other nations as of August 3, 2021.
  • The U.S. government has set a target to design, test, and approve safe vaccines within 100 days of detecting a pandemic threat, and to manufacture enough doses for the world within 200 days.
  • Global vaccine distribution is hindered by diverse national regulatory processes, varying dosage recommendations, protectionist pharmaceutical industry policies, and administrative paperwork.
  • To improve pandemic preparedness, the author recommends that the Department of Defense’s Chemical and Biological Defense Program and other agencies conduct annual exercises to improve disease detection, diagnostic testing, and vaccine manufacturing.
  • The U.S. should invest in versatile "Advanced Development and Manufacturing" facilities that can be used for biological weapons attacks or infectious disease outbreaks and kept operational through exercises or seasonal influenza responses.

Cite the original document

APA
The Council on Strategic Risks (2021). The Benefits of U.S. Vaccine Diplomacy. https://councilonstrategicrisks.org/2021/08/12/the-benefits-of-u-s-vaccine-diplomacy/
Chicago
The Council on Strategic Risks. The Benefits of U.S. Vaccine Diplomacy. 2021. https://councilonstrategicrisks.org/2021/08/12/the-benefits-of-u-s-vaccine-diplomacy/.
Wikipedia
{{cite press release |author=The Council on Strategic Risks |title=The Benefits of U.S. Vaccine Diplomacy |date=12 August 2021 |url=https://councilonstrategicrisks.org/2021/08/12/the-benefits-of-u-s-vaccine-diplomacy/ |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@misc{thecouncilonstrategicrisks2021benefits, author = {{The Council on Strategic Risks}}, title = {{The Benefits of U.S. Vaccine Diplomacy}}, publisher = {The Council on Strategic Risks}, year = {2021}, month = aug, url = {https://councilonstrategicrisks.org/2021/08/12/the-benefits-of-u-s-vaccine-diplomacy/}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated